Collaboration Milestone achieved to enable DEL for Membrane Proteins
May 9, 2023in NewsPR_Salipro_DyNAbind The two biotech companies report that they have successfully screened and identified several small molecule compounds that bind to a......
DyNAbind pitch at BioVaria 2023
April 20, 2023in EventsWe are happy to be one of the Selected Startups that gets the chance to pitch in front of selected international......
DyNAbind at Swiss Biotech Day 2023
April 20, 2023in EventsWe will be joining this year’s Swiss Biotech Day, coming up on 24 and 25 April 2023 in Basel. If......
New research publication!
March 20, 2023in NewsWe are happy to present our research collaboration results with the Yixin Zhang lab of BCUBE at TU Dresden, which were......
DyNAbind at Bio-Europe 2022
October 13, 2022in EventsFrom 24 – 26 October 2022, our team will be in Leipzig to participate in Bio-Europe – Europe’s largest biopharma partnering......
DyNAbind at the 2022 EFMC International Symposium on Medicinal Chemistry
September 5, 2022in EventsBonjour de Nice! DyNAbind’s Director of Research and Development, Francesco Reddavide, together with our senior scientist Dzung Nguyen are currently in......
DyNAbind joins the Swiss Biotech Day 2022
April 28, 2022in EventsWe’ll be joing the Swiss Biotech Day 2022 on-site in Basel next week from 02-03 May! We are very much looking......
Collaboration with Pharmacelera on AI for DEL screening
April 4, 2022in NewsDresden/Barcelona. DyNAbind and Pharmacelera are happy to announce a joint scientific collaboration in the fields of DNA-Encoded Libraries (DEL) and Artificial....